PAPA (Papa Medical) Debt-to-Equity: 0.69 (As of Mar. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Papa Medical Debt-to-Equity?

Papa Medical PAPA Debt-to-Equity is 0.69 as of Mar. 2025.

Papa Medical's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was $1.25 Mil. Papa Medical's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was $1.34 Mil. Papa Medical's Total Stockholders Equity for the quarter that ended in Mar. 2025 was $3.77 Mil. Papa Medical's debt to equity for the quarter that ended in Mar. 2025 was 0.69.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Papa Medical's Debt-to-Equity or its related term are showing as below:

PAPA's Debt-to-Equity is not ranked *
in the Tobacco Products industry.
Industry Median: 0.37
* Ranked among companies with meaningful Debt-to-Equity only.

Papa Medical  (NAS:PAPA) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Papa Medical Debt-to-Equity Related Terms

Papa Medical Debt-to-Equity Historical Data

* Premium members only.

The historical data trend for Papa Medical's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Papa Medical Debt-to-Equity Chart

Papa Medical Annual Data
Trend Dec22 Dec23 Dec24
Debt-to-Equity
0.40 0.69 0.90

Papa Medical Quarterly Data
Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only N/A 0.82 0.68 0.90 0.69

PAPA vs : Debt-to-Equity Comparison

For the Tobacco subindustry, Papa Medical's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Papa Medical Debt-to-Equity vs Tobacco Products Industry

For the Tobacco Products industry and Consumer Defensive sector, Papa Medical's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Papa Medical's Debt-to-Equity falls into.


Papa Medical Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Papa Medical's Debt to Equity Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(1.041 + 1.624) / 2.979
=0.89

Papa Medical's Debt to Equity Ratio for the quarter that ended in Mar. 2025 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(1.252 + 1.34) / 3.768
=0.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Equity →
What does a Debt-to-Equity of 0.69 mean?
Papa Medical (PAPA) has a Debt-to-Equity of 0.69 as of Mar. 2025. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Papa Medical and its competitors.
Is Papa Medical's Debt-to-Equity too high?
Papa Medical's current Debt-to-Equity is 0.69. The Tobacco Products industry median Debt-to-Equity is 0.37. Papa Medical's value of 0.69 is 86.5% above this industry median.
How does Papa Medical's Debt-to-Equity compare to ?
Papa Medical's Debt-to-Equity of 0.69 can be compared against companies in the Tobacco Products industry. The industry median Debt-to-Equity is 0.37. Papa Medical's value of 0.69 is 86.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Tobacco Products company?
The median Debt-to-Equity among Tobacco Products companies is 0.37, based on 35 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Papa Medical's current Debt-to-Equity of 0.69 is 86.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Papa Medical and its competitors. For the Tobacco Products industry, the median Debt-to-Equity is 0.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Papa Medical's current Debt-to-Equity is 0.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Papa Medical stock overvalued right now?
Papa Medical (PAPA) has a current Debt-to-Equity of 0.69. The current Debt-to-Equity is 0.69 and 86.5% above the Tobacco Products industry median of 0.37. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Papa Medical (PAPA), the current Debt-to-Equity is 0.69 as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Papa Medical Business Description

Comparable Companies
Address 202 North California Ave, City of Industry, CA, USA, 91744
Papa Medical Inc is the first end-to-end cannabis dosing solution provider in the U.S. that possesses the medical atomization or nebulizing background and sells nebulizers. The company deeply engages in key activities in the cannabis and consuming E-vapors industry, from research and development, formulation design, e-liquid production, and e-liquid filling to e-liquid co-packing services. It is engaged in the research and development, design, commercialization, sales, marketing and distribution of branded e-cigarettes and cannabis E-vapors.